Binding of CCCTC-binding factor in vivo to the region located between Rep* and the C promoterof Epstein-Barr virus is unaffected by CpG methylation and does not correlate with Cp activity

Journal of General Virology

Volumn 90, Issue 5, 2009, Pages 1183-1189

  Salamon, Daniel ^a   Banati, Ferenc ^a   Koroknai, Anita ^a   Ravasz, Mate ^a   Szenthe, Kalman ^a   Bathori, Zoltan ^a   Bakos, Agnes ^a   Niller, Hans Helmut ^b   Wolf, Hans ^b   Minarovits, Janos ^a  

^a NATIONAL CENTER FOR EPIDEMIOLOGY   (Hungary)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BISULFITE; CCCTC BINDING FACTOR; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; CCCTC-BINDING FACTOR; DNA BINDING PROTEIN; EPSTEIN BARR VIRUS ANTIGEN; REPRESSOR PROTEIN;

ARTICLE; BINDING SITE; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; CPG ISLAND; DEMETHYLATION; DNA FOOTPRINTING; DNA METHYLATION; EPSTEIN BARR VIRUS; GEL MOBILITY SHIFT ASSAY; GENE SEQUENCE; IN VIVO STUDY; LATENT PERIOD; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; METABOLISM; METHYLATION; MOLECULAR GENETICS; PHYSIOLOGY; PROMOTER REGION; VIRUS GENOME; VIRUS LATENCY;

HUMAN HERPESVIRUS 4;

BINDING SITES; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; CPG ISLANDS; DNA-BINDING PROTEINS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; GENE EXPRESSION REGULATION, VIRAL; GENOME, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; METHYLATION; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; REPRESSOR PROTEINS; TRANSCRIPTION, GENETIC; VIRUS LATENCY;

EID: 67449097317     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.007344-0     Document Type: Article

References (34)

1. Altiok, E., Minarovits, J., Hu, L. F., Contreras-Brodin, B., Klein, G. & Ernberg, I. (1992). Host-cell-phenotype-dependent control of the BCR2/BWR1 promoter complex regulates the expression of Epstein-Barr virus nuclear antigens 2-6. Proc Natl Acad Sci U S A 89, 905-909.
2. Baer, R., Bankier, A. T., Biggin, M. D., Deininger, P. L., Farrel, P. J., Gibson, T. G., Hatfull, G., Hudson, G. S., Satchwell, S. C. & other authors (1984). DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310, 207-211.
3. Bakos, A., Banati, F., Koroknai, A., Takacs, M., Salamon, D., Minarovits-Kormuta, S., Schwarzmann, F., Wolf, H., Niller, H. H. & Minarovits, J. (2007). High resolution analysis of CpG methylation and in vivo protein-DNA interactions at the alternative Epstein-Barr virus latency promoters Qp and Cp in the nasopharyngeal carcinoma cell line C666-1. Virus Genes 35, 195-202.
4. Banati, F., Koroknai, A., Salamon, D., Takacs, M., Minarovits-Kormuta, S., Wolf, H., Niller, H. H. & Minarovits, J. (2008). CpG-methylation silences the activity of the RNA polymerase III transcribed EBER-1 promoter of Epstein-Barr virus. FEBS Lett 582, 705-709.
5. Busson, P., Ganem, G., Flores, P., Muqneret, F., Clausse, B., Caillou, B., Braham, K., Wakasugi, H., Lipinski, M. & Tursz, T. (1988). Establishment and characterization of three transplantable EBV-containing nasopharyngeal carcinomas. Int J Cancer 42, 599-606.
6. Chau, C. M., Zhang, X. Y., McMahon, S. B. & Lieberman, P. M. (2006). Regulation of Epstein-Barr virus latency type by the chromatin boundary factor CTCF. J Virol 80, 5723-5732.
7. Cheung, S. T., Huang, D. P., Hui, A. B., Lo, K. W., Ko, C. W., Tsang, Y. S., Wong, N., Whitney, B. M. & Lee, J. C. (1999). Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus. Int J Cancer 83, 121-126.
8. Day, L., Chau, C. M., Nebozhyn, M., Rennekamp, A. J., Showe, M. & Lieberman, P. M. (2007). Chromatin profiling of Epstein-Barr virus latency control region. J Virol 81, 6389-6401.
9. Ernberg, I., Falk, K., Minarovits, J., Busson, P., Tursz, T., Masucci, M. G. & Klein, G. (1989). The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus. J Gen Virol 70, 2989-3002.
10. Falk, K. I., Szekely, L., Aleman, A. & Ernberg, I. (1998). Specific methylation patterns in two control regions of Epstein-Barr virus latency: The LMP-1-coding upstream regulatory region and an origin of DNA replication (oriP). J Virol 72, 2969-2974.
11. Fejer, G., Koroknai, A., Banati, F., Gyory, I., Salamon, D., Wolf, H., Niller, H. H. & Minarovits, J. (2008). Latency type-specific distribution of epigenetic marks at the alternative promoters Cp and Qp of Epstein-Barr virus. J Gen Virol 89, 1364-1370.
12. Filippova, G. N. (2008). Genetics and epigenetics of the multi-functional protein CTCF. Curr Top Dev Biol 80, 337-360.
13. Gerle, B., Koroknai, A., Fejer, G., Bakos, A., Banati, F., Szenthe, K., Wolf, H., Niller, H. H., Minarovits, J. & Salamon, D. (2007). Acetylated histone H3 and H4 mark the upregulated LMP2A promoter of Epstein-Barr virus in lymphoid cells. J Virol 81, 13242-13247.
14. Gregory, C. D., Rowe, M. & Rickinson, A. B. (1990). Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line. J Gen Virol 71, 1481-1495.
15. Jones, M. D., Foster, L., Sheedy, T. & Griffin, B. E. (1984). The EB virus genome in Daudi Burkitt's lymphoma cells has a deletion similar to that observed in a non-transforming strain (P3HR-1) of the virus. EMBO J 3, 813-821.
16. Kavathas, P., Bach, F. H. & DeMars, R. (1980). Gamma ray-induced loss of expression of HLA and glyoxalase I alleles in lymphoblastoid cells. Proc Natl Acad Sci U S A 77, 4251-4255.
17. Lenoir, G. M., Vuillaume, M. & Bonnardel, C. (1985). The use of lymphomatous and lymphoblastoid cell lines in the study of Burkitt's lymphoma. IARC Sci Publ 60, 309-318.
18. Liebowitz, D. (1998). Epstein-Barr virus pathogenesis. In Human Tumor Viruses, pp. 173-199. Edited by D. J. McCance. Washington, DC: American Society for Microbiology.
19. Minarovits, J., Minarovits-Kormuta, S., Ehlin-Henriksson, B., Falk, K., Klein, G. & Ernberg, I. (1991). Host cell phenotype-dependent methylation patterns of Epstein-Barr virus DNA. J Gen Virol 72, 1591-1599.
20. Minarovits, J., Hu, L. F., Marcsek, Z., Minarovits-Kormuta, S., Klein, G. & Ernberg, I. (1992). RNA polymerase III-transcribed EBER 1 and 2 transcription units are expressed and hypomethylated in the major Epstein-Barr virus-carrying cell types. J Gen Virol 73, 1687-1692.
21. Mukhopadhyay, R., Yu, W., Whitehead, J., Xu, J., Lezcano, M., Pack, S., Kanduri, C., Kanduri, M., Ginjala, V. & other authors (2004). The binding sites for the chromatin insulator protein CTCF map to DNA methylation-free domains genome-wide. Genome Res 14, 1594-1602.
22. Niller, H. H., Salamon, D., Takacs, M., Uhlig, J., Wolf, H. & Minarovits, J. (2001). Protein-DNA interaction and CpG methylation at rep vIL-10p of latent Epstein-Barr virus genomes in lymphoid cell lines. Biol Chem 382, 1411-1419.
23. Niller, H. H., Salamon, D., Ilg, K., Koroknai, A., Banati, F., Bauml, G., Rücker, O. L., Schwarzmann, F., Wolf, H. & Minarovits, J. (2003). The in vivo binding site for oncoprotein c-Myc in the promoter for Epstein-Barr virus (EBV) encoding RNA (EBER) 1 suggests a specific role for EBV in lymphomagenesis. Med Sci Monit 9, 1-9.
24. Ohlsson, R., Renkawitz, R. & Lobanenkov, V. (2001). CTCF is a uniquely versatile transcription regulator linked to epigenetics and disease. Trends Genet 17, 520-527.
25. Robertson, K. D. & Ambinder, R. F. (1997). Methylation of the Epstein-Barr virus genome in normal lymphocytes. Blood 90, 4480-4484.
26. Robertson, K. D., Hayward, S. D., Ling, P. D., Samid, D. & Ambinder, R. F. (1995). Transcriptional activation of the Epstein-Barr virus latency C promoter after 5-azacytidine treatment: evidence that demethylation at a single CpG site is crucial. Mol Cell Biol 15, 6150-6159.
27. Salamon, D., Takacs, M., Myöhänen, S., Marcsek, Z., Berencsi, G. & Minarovits, J. (2000). De novo DNA methylation at nonrandom founder sites 5′ from an unmethylated minimal origin of DNA replication in latent Epstein-Barr virus genomes. Biol Chem 381, 95-105.
28. Salamon, D., Takacs, M., Ujvari, D., Uhlig, J., Wolf, H., Minarovits, J. & Niller, H. H. (2001). Protein-DNA binding and CpG methylation at nucleotide resolution of latency-associated promoters Qp, Cp and LMP1p of Epstein-Barr virus. J Virol 75, 2584-2596.
29. Salamon, D., Takacs, M., Schwarzmann, F., Wolf, H., Minarovits, J. & Niller, H. H. (2003). High-resolution methylation analysis and in vivo protein-DNA binding at the promoter of the viral oncogene LMP2A in B cell lines carrying latent Epstein-Barr virus genomes. Virus Genes 27, 57-66.
30. Schaefer, B. C., Strominger, J. L. & Speck, S. H. (1997). Host-cell-determined methylation of specific Epstein-Barr virus promoters regulates the choice between distinct viral latency programs. Mol Cell Biol 17, 364-377.
31. Takacs, M., Salamon, D., Myöhänen, S., Li, H., Segesdi, J., Ujvari, D., Uhlig, J., Niller, H. H., Wolf, H. & other authors (2001). Epigenetics of latent Epstein-Barr virus genomes: High resolution methylation analysis of the bidirectional promoter region of latent membrane protein 1 and latent membrane protein 2B genes. Biol Chem 382, 699-705.
32. Tao, Q., Robertson, K. D., Manns, A., Hildesheim, A. & Ambinder, R. F. (1998). The Epstein-Barr virus major latent promoter Qp is constitutively active, hypomethylated, and methylation sensitive. J Virol 72, 7075-7083.
33. Walls, D. & Perricaudet, M. (1991). Novel downstream elements upregulate transcription initiated from an Epstein-Barr virus latent promoter. EMBO J 10, 143-151.
34. Woisetschlaeger, M., Strominger, J. L. & Speck, S. H. (1989). Mutually exclusive use of viral promoters in Epstein-Barr virus latently infected lymphocytes. Proc Natl Acad Sci U S A 86, 6498-6502.